Approval · Notice of Compliance 18340 · 2016
ACYCLOVIR SODIUM INJECTION: Notice of Compliance 18340
Issued August 5, 2016
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18340
- Date
- August 5, 2016
- Company
- Hospira Healthcare CorporationKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Reivisions to the labels, package insertn and prescribing information
- Canadian reference product
- ZOVIRAX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION | 02236916 | Cancelled Post Market |
Medicinal ingredients
- ACYCLOVIR SODIUM 25 MG per ML